BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23059147)

  • 21. [Clinical pharmacogenetics in the treatment of schizophrenia].
    Furukori N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):65-9. PubMed ID: 20491279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pimozide for Tourette's disorder.
    Med Lett Drugs Ther; 1985 Jan; 27(678):3-4. PubMed ID: 3855327
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.
    van der Padt A; van Schaik RH; Sonneveld P
    Neth J Med; 2006 May; 64(5):160-2. PubMed ID: 16702617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pimozide treatment of tic and Tourette disorders.
    Shapiro AK; Shapiro E; Fulop G
    Pediatrics; 1987 Jun; 79(6):1032-9. PubMed ID: 3295739
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.
    Rizzo R; Eddy CM; Calí P; Gulisano M; Cavanna AE
    Pediatr Neurol; 2012 Dec; 47(6):419-22. PubMed ID: 23127261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.
    van der Linden C; Bruggeman R; van Woerkom TC
    Mov Disord; 1994 Nov; 9(6):687-8. PubMed ID: 7531282
    [No Abstract]   [Full Text] [Related]  

  • 28. Tourette syndrome: clinical characteristics and current management strategies.
    Kossoff EH; Singer HS
    Paediatr Drugs; 2001; 3(5):355-63. PubMed ID: 11393328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS; Moldofsky H
    Am J Psychiatry; 1978 May; 135(5):585-7. PubMed ID: 347954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
    Lang AE
    Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ECG changes during haloperidol and pimozide treatment of Tourette's disorder.
    Fulop G; Phillips RA; Shapiro AK; Gomes JA; Shapiro E; Nordlie JW
    Am J Psychiatry; 1987 May; 144(5):673-5. PubMed ID: 3555126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
    Wijemanne S; Wu LJ; Jankovic J
    Mov Disord; 2014 Jan; 29(1):126-30. PubMed ID: 24150997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of CYP2D6 genotype and response to tetrabenazine.
    Mehanna R; Hunter C; Davidson A; Jimenez-Shahed J; Jankovic J
    Mov Disord; 2013 Feb; 28(2):210-5. PubMed ID: 23280482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Tourette syndrome].
    Pushkov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(10):1476-9. PubMed ID: 2880439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gilles de la Tourette syndrome].
    Sell-Salazar F
    Rev Neurol; 2000 Aug 16-31; 31(4):353-6. PubMed ID: 11008291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E; Shapiro AK
    Adv Neurol; 1982; 35():413. PubMed ID: 6959518
    [No Abstract]   [Full Text] [Related]  

  • 37. Pimozide-induced enuresis.
    Shapiro AK
    Am J Psychiatry; 1981 Jan; 138(1):123-4. PubMed ID: 6934699
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR; Dougherty D; Sethuraman G; Vrindavanam N
    Biol Psychiatry; 1996 Nov; 40(10):1044-50. PubMed ID: 8915564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance and challenges of developing a pharmacogenetics test for hypertension.
    Snyder EM; Kelley EF; Sprissler R; Olson TP
    Pharmacogenomics; 2019 Jun; 20(8):563-566. PubMed ID: 31136254
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetics, haloperidol and pimozide: a comparative study in two mouse strains.
    Messiha FS
    Neurotoxicology; 1991; 12(1):47-54. PubMed ID: 2014068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.